Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.936 USD | +2.58% | -8.52% | -32.38% |
Mar. 27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
Mar. 27 | Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating | MT |
Financials (USD)
Sales 2023 * | 37.41M | Sales 2024 * | 125M | Capitalization | 176M |
---|---|---|---|---|---|
Net income 2023 * | -199M | Net income 2024 * | -236M | EV / Sales 2023 * | -1.73 x |
Net cash position 2023 * | 241M | Net cash position 2024 * | 106M | EV / Sales 2024 * | 0.56 x |
P/E ratio 2023 * |
-0.55
x | P/E ratio 2024 * |
-0.57
x | Employees | 323 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.62% |
Latest transcript on bluebird bio, Inc.
1 day | -1.13% | ||
1 week | -4.25% | ||
Current month | -28.71% | ||
1 month | -32.90% | ||
3 months | -18.53% | ||
6 months | -68.64% | ||
Current year | -33.88% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 51 | 15-12-31 |
Director of Finance/CFO | 51 | 22-11-06 | |
Melissa Bonner
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Vachon
CHM | Chairman | 65 | 14-07-15 |
Nick Leschly
BRD | Director/Board Member | 51 | 10-02-28 |
Richard Paulson
BRD | Director/Board Member | 56 | 23-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 16 M€ | -8.49% | ||
0.11% | 237 M€ | +1.04% | - | |
0.10% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.9218 | +1.02% | 4 283 947 |
24-04-25 | 0.9125 | -1.13% | 5,710,286 |
24-04-24 | 0.9229 | -4.91% | 8,181,045 |
24-04-23 | 0.9706 | +1.78% | 4,789,119 |
24-04-22 | 0.9536 | -6.51% | 4,581,972 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.88% | 176M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.41% | 22.02B | |
-17.84% | 20.9B | |
-8.79% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- BLUE Stock